Alector
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
131 Oyster Point Blvd Ste 600, South San...Phone Number
(415) 231-5660Website
www.alector.comRevenue
$18.4 MillionStock Symbol
ALECIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About Alector
Founded in 2013, Alector focuses on the research and preventative development of neurodegenerative diseases among elderly populations. Some of the diseases they conduct research on include Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and more. This company is headquartered in South San Francisco, California.Explore more
Alector Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Alector your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Alector has recently received funding, and reach out quickly before it becomes old news!
Click to see if Alector had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Alector
Funding: Get notified immidiatlly once Alector has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Alector launches new products
Alector, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Alector is spiking on competitors!
Earning: See what the market has to say on Alector recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Alector as Masked Content
Find more new buyers
Compare Similar Companies to Alector
Compare insights from companies similar to Alector, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alector is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Alector is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Alector.
Alector financials insights
Gather financial insights about Alector, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series C
$32M
2016
Series D
$29.5M
2018
Series E
$133M
2019
Stock Offering
$176M
2024
Debt
$50M
Debt
$10M
Alector Tech Stack
A closer look at the technologies used by Alector
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Open Position
Person-Based
Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Medical Research, Clinical Operations
Alector News & Media
Alector to Discontinue Phase 2 PROGRESS-AD Trial of Nivisnebart (AL101/GSK4527226) in Early Alzheimer’s Disease Following Interim Futility Analysis
--Independent data monitoring committee (IDMC) determined the trial unlikely to meet primary endpoint –Alector, Inc. (ALEC) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Alector, Inc. (ALEC) TD Cowen 46th Annual Health Care Conference March 3, 2026 3:10 PM ESTCompany ParticipantsEric BrownGiacomo Salvadore - Chief Medical...Alector Showcases ABC Brain-Delivery Platform, AL137 and AL050 Updates at TD Cowen Conference
Alector (NASDAQ:ALEC) used a presentation at the 46th Annual TD Cowen Healthcare Conference to highlight progress on its Alector Brain Carrier (ABC) platform, which is designed to deliver multiple therapeutic “cargos” across the blood-brain barrier using the transferrin receptor (TfR). Eric Brown, hAlector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Advancing the Alector Brain Carrier (ABC) platform across multiple therapeutic modalities, including antibodies, enzymes, and siRNA, with continued progress across AL137 (ABC-enabled anti-amyloid antibody for Alzheimer’s Disease), AL050 (ABC-enabled GCase Enzyme Replacement Therapy for Parkinson’s Disease) and AL064 (ABC-enabled Tau siRNA for Alzheimer’s Disease)
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Alector
Sign Up For FreeTo access detailed company insights
Founded in 2013, Alector focuses on the research and preventative development of neurodegenerative diseases among elderly populations. Some of the diseases they conduct research on include Alzheimer's, Parkinson's, amyotrophic lateral sclerosis, and more. This company is headquartered in South San Francisco, California.... Read More
